- Report from the 2008 joint ICAAC/IDSA meeting. Bevirimat: predictors of response. [Congress]AIDS Clin Care. 2008 Dec; 20(12):104.AC
- Report from the 2008 joint ICAAC/IDSA meeting. Maraviroc vs. efavirenz: a reanalysis of MERIT. [Congress]AIDS Clin Care. 2008 Dec; 20(12):98, 104.AC
- Report from the 2008 joint ICAAC/IDSA meeting. More on raltegravir: resistance and mechanisms of action. [Congress]AIDS Clin Care. 2008 Dec; 20(12):97-8.AC
- Report from the 2008 joint ICAAC/IDSA meeting. Raltegravir vs. efavirenz in treatment-naive patients. [Congress]AIDS Clin Care. 2008 Dec; 20(12):97.AC
- A single case of cure? [Case Reports]AIDS Clin Care. 2008 Dec; 20(12):103.AC
- Darunavir now approved for use in treatment-naive patients. [Newspaper Article]AIDS Clin Care. 2008 Dec; 20(12):102.AC
- New DHHS guidelines shuffle drug rankings. [Newspaper Article]AIDS Clin Care. 2008 Dec; 20(12):101.AC
- Report from the 2008 joint ICAAC/IDSA meeting. More data on abacavir/3TC. [Congress]AIDS Clin Care. 2008 Dec; 20(12):104.AC
- Report from the 2008 joint ICAAC/IDSA meeting. Darunavir and atazanavir: 96-week data from ARTEMIS and CASTLE. [Congress]AIDS Clin Care. 2008 Dec; 20(12):98.AC
- Report from the 2008 joint ICAAC/IDSA meeting. Early ART and overall survival. [Congress]AIDS Clin Care. 2008 Dec; 20(12):97.AC
- Report from the 15th Retrovirus Conference. Expanding HIV treatment options during pregnancy. [Congress]AIDS Clin Care. 2008 Apr; 20(4):30-1.AC
- Report from the 15th Retrovirus Conference. Etravirine resistance: baseline prevalence and proposed criteria for "vircotype". [Congress]AIDS Clin Care. 2008 Apr; 20(4):30.AC
- Report from the 15th Retrovirus Conference. Opportunistic infections: TB, HIV and XDR TB. [Congress]AIDS Clin Care. 2008 Apr; 20(4):29.AC